Abrdn Healthcare Investors
$18.70
$-0.17 (-0.90%)
Jan 5, 2026
Price History (1Y)
Analysis
Abrdn Healthcare Investors is a financial services company in the asset management industry. It has a market capitalization of $1.04B and annual revenue of $7.53M, indicating a relatively small scale operation. The company's financial health is mixed. Despite a high profit margin of 1309.0%, it also reports a significant operating loss, with an operating margin of -88.1%. The return on equity (ROE) stands at 9.2%, while the return on assets (ROA) is negative at -0.2%. The company's valuation context shows a price-to-earnings ratio (P/E) of 11.69 and a significant dividend yield of 1161.0%. The revenue growth rate has declined by 48.7% year-over-year, while earnings growth has increased by 91.1%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Key Statistics
- Market Cap
- $1.04B
- P/E Ratio
- 11.69
- 52-Week High
- $19.69
- 52-Week Low
- $13.77
- Avg Volume
- 194.13K
- Beta
- 0.71
- Dividend Yield
- 1161.00%
Company Info
- Industry
- Asset Management
- Exchange
- NYQ
- Country
- United States